Dr. S. Anjani Devi Mattai, MD

Dr. Mattai practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Mattai's NPI, 1528030996, was assigned on February 1, 2006. Dr. Mattai graduated from Feinberg School of Medicine in 1996. Dr. Mattai's California license number on file is A69997.

Dr. Mattai's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Mattai's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Mattai is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Mattai to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mattai practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mattai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mattai is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mattai's licenses on file in 2 states: California and New York.

Dmand AI lists acid reflux, acute skin infection, adjustment disease, aneurysm, atrial fibrillation and flutter, chronic diabetes, chronic hypertension and chronic kidney disease among the conditions Dr. Mattai treats.

CMS data shows 371 Medicare services from Dr. Mattai across 7 procedure codes in 2024, for 134 Medicare patients. Medicare paid $18,852 for them.

CMS counts 134 Medicare patients who saw Dr. Mattai in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mattai's median patient age at 57, with 62% women.

In 2024, Dr. Mattai wrote 1,063 Medicare Part D claims for 162 patients. 93% of them were for generic drugs. CMS names the drug for 736 of them, across 24 drugs with 11 or more claims each, at $30,364 in total drug cost. In 2023, CMS named 1,108 claims across 34 drugs.

Dr. Mattai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mattai as offering telehealth.

Dmand AI lists 1 award for Dr. Mattai, most recently CMS Stage 1 EHR in 2013.

Dr. Mattai graduated from Feinberg School of Medicine in 1996.

Dr. Mattai is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.